Sign in
Taking people in United StatesNo phase

Studying tumor genes and life factors in adults with meningioma

Looks at how health risks and social conditions relate to meningioma in adults.

Key facts

Who runs it
University of California, San Francisco
Where
San Francisco, United StatesSee the site
Trial code
Registry title
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
Status
Recruiting
People taking part
3,000 people, planned
Started
16 Jan 2026
Expected to end
1 Jan 2032
Type of study
Observational
Treatments tested
  • Questionnaire
  • Medical Record Review
Record updated
19 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults diagnosed with a meningioma, a common brain tumor. Participants fill in a one-time survey of about 20 minutes, and their medical records are reviewed.

Age
18 years and older
Sex
All sexes
Disease stage
Any diagnosed meningioma

Main reasons for not taking part

  • Active psychiatric issues, such as suicidal thoughts, active psychosis or grave disability
  • Cannot give consent because of a severe brain or nerve problem or psychiatric distress
  • Cannot complete the survey because of a severe brain or nerve problem or psychiatric distress
  • Cannot speak and read English

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Adults ≥18 years of age
  • Able to speak and read English
  • Diagnosed with a meningioma

Who cannot take part

  • Active psychiatric issues (suicidality, active psychosis, grave disability, etc.)
  • Inability to consent secondary to severe neurologic deficit or psychiatric distress
  • Inability to complete survey secondary to severe neurologic deficit or psychiatric distress

Where in United States

  • University of California San FranciscoSan Francisco, United StatesContact: Zora ArumTaking people

About the trial

What the trial wants to find out

Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.

The group in the trial

  • Participants with Meningioma

    Adult patients who have been diagnosed with a meningioma will be asked to complete a one-time survey, which will take roughly 20 minutes to complete. Participants will also have medical records reviewed to capture additional data relating to the participants medical history.

    Treatment: Questionnaire and Medical Record Review

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
An Investigation of Tumor Genomics, Individual Risk Factors, and External Drivers of Health to Improve Health Outcomes for Patients With Meningioma
Plain-language title
Studying tumor genes and life factors in adults with meningiomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
19 May 2026